News

Filter

Current filters:

TransgeneResearch

Transgene's Pexa-Vec fails in mid-stage liver cancer study

04-09-2013

French biotech firm Transgene (Euronext Paris: TNG) has revealed that TRAVERSE, a randomized Phase IIb…

BiotechnologyOncologyPexa-VecResearchTransgene

Transgene to seek partner for HCV vaccine TG4040 on strong Ph II results

09-11-2011

French biotech firm Transgene (Euronext Paris: FR0005175080) has revealed interim data showing a substantial…

BiotechnologyLicensingOncologyPharmaceuticalResearchTransgeneVaccines

Transgene, ChronTech Pharma and Inovio to collaborate on hep C vaccine

21-04-2011

France’s Transgene (Euronext Paris: FR0005175080) has signed a collaboration agreement with Sweden’s…

Anti-viralsChronTech PharmaInovio PharmaceuticalsPharmaceuticalResearchTransgeneVaccines

Roche pulls out of Papilloma virus deal with Transgene

24-02-2011

Swiss drug major Roche (SIX: ROG) has terminated its 2007 agreement under which France’s Transgene…

Anti-viralsLicensingPharmaceuticalResearchRocheTransgeneVaccines

COMPANY SPOTLIGHT

Menarini

Back to top